B. Riley Securities, Inc. Sorrento Therapeutics, Inc. Transaction History
B. Riley Securities, Inc.
- $460 Billion
- Q4 2022
A detailed history of B. Riley Securities, Inc. transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, B. Riley Securities, Inc. holds 5,216,250 shares of SRNE stock, worth $1.72 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
5,216,250Holding current value
$1.72 Million% of portfolio
1.01%Shares
1 transactions
Others Institutions Holding SRNE
# of Institutions
12Shares Held
5.47MCall Options Held
0Put Options Held
0-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
Lattice Capital Management, LLC51.8KShares$17,0940.02% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
-
Slate Stone Wealth, LLC21.4KShares$7,0720.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...